Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-038973

SVP & Chief Operating Officer sold 101,700 shares at $19.24 ($1,956,708)

  • SVP & Chief Operating Officer acquired 150,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nicholson John SVP & Chief Operating Officer 2017-06-07 Option exercise +150,000 $6.34 $951,000 328,943 D: show line 1 in the form
Nicholson John SVP & Chief Operating Officer 2017-06-07 Sale −101,700 $19.24 $1,956,708 227,243 D: show line 2 in the form
Open-market sales · 101,700 sh · avg $19.24 · $1,956,708

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Nicholson John SVP & Chief Operating Officer 2017-06-07 Option exercise · Stock Option −150,000 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…